We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00681382
First Posted: May 21, 2008
Last Update Posted: January 24, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
  Purpose
This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.

Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Patients perceptions about treatment of asthma, asthma medication and what are the most common triggers that cause exacerbations. [ Time Frame: Single occasion ]

Secondary Outcome Measures:
  • How patients react to the first signs of worsening of asthma i.e. how they use asthma medication during stable phase and asthma exacerbation [ Time Frame: Single occasion ]
  • How asthma affects everyday life [ Time Frame: Single occasion ]

Enrollment: 142
Study Start Date: October 2006
Study Completion Date: April 2007
Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Asthma patients using inhaled steroids as maintenance treatment

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • Diagnosed persistent asthma
  • regular use of inhaled steroids and concomitant medication

Exclusion Criteria:

  • never been diagnosed COPD
  • seasonal asthma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00681382


Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Airi Puhakka AstraZeneca Finland
Principal Investigator: Jouni Hedman South Karelia Central Hospital, Finland
  More Information

Responsible Party: Klaus Tamminen - MC Medical Director, AstraZeneca
ClinicalTrials.gov Identifier: NCT00681382     History of Changes
Other Study ID Numbers: NIS-RFI-SYM-2006/1
First Submitted: May 19, 2008
First Posted: May 21, 2008
Last Update Posted: January 24, 2011
Last Verified: January 2011

Keywords provided by AstraZeneca:
Asthma
use of asthma medication
asthma control
telephone survey
patient's perception

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases